CEL-SCI CORPORATION Proceeds from Common Stock Issued
CEL-SCI CORPORATION (CVM) reported Proceeds from Common Stock Issued of $9.70 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- CEL-SCI CORPORATION proceeds from issuance of common stock for the quarter ending 2026-06-30 was $9.70M, a 94.00% increase year-over-year.
- CEL-SCI CORPORATION proceeds from issuance of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION proceeds from issuance of common stock for the quarter ending 2025-09-30 was $15.73M, a 45.05% increase year-over-year.
- CEL-SCI CORPORATION proceeds from issuance of common stock for fiscal 2025 was $28.29M, a 20.00% increase from fiscal 2024.
- CEL-SCI CORPORATION proceeds from issuance of common stock for fiscal 2024 was $23.57M, a 259.79% increase from fiscal 2023.
- CEL-SCI CORPORATION proceeds from issuance of common stock for fiscal 2023 was $6.55M.
- CEL-SCI CORPORATION proceeds from issuance of common stock for fiscal 2021 was $47.36M, a 238.49% increase from fiscal 2020.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 1 month as first filed | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.20M 10-Q · filed 2026-08-14 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $9.70M derived: sum of 2 quarters · filed 2026-08-14 | $9.70M 10-Q · filed 2026-08-14 | $25.43M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-05-31 | $6.40M 10-Q · filed 2026-08-14 | |||||||||
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $0.00 10-Q · filed 2026-05-15 | $15.73M derived: sum of 3 quarters · filed 2026-05-15 | $20.73M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-17 | $15.73M derived: sum of 2 quarters · filed 2026-02-17 | $20.73M derived: sum of 3 quarters · filed 2026-08-14 | $23.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-09-30 | $15.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $20.73M derived: sum of 2 quarters · filed 2026-08-14 | $23.29M derived: sum of 3 quarters · filed 2026-08-14 | $28.29M 10-K · filed 2025-12-29 | ||||||
| 2025-08-31 | $9.00M 10-K · filed 2025-12-29 | |||||||||
| 2025-07-31 | $5.10M 10-K · filed 2025-12-29 | |||||||||
| 2025-06-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $7.56M derived: sum of 2 quarters · filed 2026-08-14 | $12.56M 10-Q · filed 2026-08-14 | $23.41M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-05-31 | $4.50M 10-Q · filed 2026-08-14 | |||||||||
| 2025-03-31 | $2.10M 10-Q · filed 2026-08-14 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $7.56M 10-Q · filed 2026-05-15 | $18.41M derived: sum of 3 quarters · filed 2026-05-15 | $18.41M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $4.40M 10-Q · filed 2026-08-14 | $5.00M 10-Q · filed 2026-02-17 | $15.85M derived: sum of 2 quarters · filed 2026-02-17 | $15.85M derived: sum of 3 quarters · filed 2026-02-17 | $23.60M derived: sum of 4 quarters · filed 2026-02-17 | |||||
| 2024-09-30 | $10.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $10.85M derived: sum of 2 quarters · filed 2025-12-29 | $18.59M derived: sum of 3 quarters · filed 2025-12-29 | $23.57M 10-K · filed 2025-12-29 | ||||||
| 2024-07-29 | $9.70M 10-K · filed 2025-12-29 | |||||||||
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $7.75M derived: sum of 2 quarters · filed 2025-08-14 | $12.73M 10-Q · filed 2025-08-14 | $17.73M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | $7.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $12.73M 10-Q · filed 2025-05-14 | $17.73M derived: sum of 3 quarters · filed 2025-05-14 | $19.28M derived: sum of 4 quarters · filed 2025-05-14 | ||||||
| 2024-02-29 | $7.00M 10-K · filed 2025-12-29 | |||||||||
| 2023-12-31 | $4.98M 10-Q · filed 2025-02-14 | $9.98M derived: sum of 2 quarters · filed 2025-02-14 | $11.53M derived: sum of 3 quarters · filed 2025-02-14 | $11.53M derived: sum of 4 quarters · filed 2025-02-14 | ||||||
| 2023-11-30 | $4.50M 10-K · filed 2025-12-29 | $5.00M 10-Q · filed 2024-02-14 | ||||||||
| 2023-09-30 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | $6.55M derived: sum of 2 quarters · filed 2025-01-13 | $6.55M derived: sum of 3 quarters · filed 2025-01-13 | $6.55M 10-K · filed 2025-01-13 | ||||||
| 2023-06-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $1.55M derived: sum of 2 quarters · filed 2024-08-14 | $1.55M 10-Q · filed 2024-08-14 | $1.39M 10-Q · filed 2023-08-10 | ||||||
| 2023-04-30 | $1.20M 10-Q · filed 2023-08-10 | |||||||||
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | $0.00 10-Q · filed 2024-05-15 | ||||||||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-14 | |||||||||
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||||||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | |||||||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $60.92M derived: sum of 2 quarters · filed 2022-08-12 | $33.80M derived: sum of 3 quarters · filed 2022-08-12 | $47.36M 10-K · filed 2021-12-21 | ||||||
| 2021-06-30 | $60.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $33.80M derived: sum of 2 quarters · filed 2022-08-12 | $47.36M 10-Q · filed 2022-08-12 | $47.36M derived: sum of 4 quarters · filed 2022-08-12 | ||||||
| 2021-03-31 | -$27.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$13.56M 10-Q · filed 2022-05-13 | $13.56M 10-Q · filed 2021-05-17 | -$13.56M derived: sum of 3 quarters · filed 2022-05-13 | -$12.48M derived: sum of 4 quarters · filed 2022-05-13 | |||||
| 2020-12-31 | $13.56M 10-Q · filed 2022-02-11 | $13.56M derived: sum of 2 quarters · filed 2022-02-11 | $14.63M derived: sum of 3 quarters · filed 2022-02-11 | $22.50M derived: sum of 4 quarters · filed 2022-02-11 | ||||||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $1.07M derived: sum of 2 quarters · filed 2021-12-21 | $8.94M derived: sum of 3 quarters · filed 2021-12-21 | $13.99M 10-K · filed 2021-12-21 | ||||||
| 2020-06-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $8.94M derived: sum of 2 quarters · filed 2021-08-13 | $13.99M 10-Q · filed 2021-08-13 | $13.99M derived: sum of 4 quarters · filed 2021-08-13 | ||||||
| 2020-03-31 | $7.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | $12.92M 10-Q · filed 2021-05-17 | $12.92M derived: sum of 3 quarters · filed 2021-05-17 | $12.92M derived: sum of 4 quarters · filed 2021-05-17 | ||||||
| 2019-12-31 | $5.05M 10-Q · filed 2021-02-12 | $5.05M derived: sum of 2 quarters · filed 2021-02-12 | $5.05M derived: sum of 3 quarters · filed 2021-02-12 | $5.05M derived: sum of 4 quarters · filed 2021-02-12 | ||||||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | $0.00 derived: sum of 2 quarters · filed 2020-12-31 | $0.00 derived: sum of 3 quarters · filed 2020-12-31 | $0.00 10-K · filed 2020-12-29 | ||||||
| 2019-06-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | $0.00 derived: sum of 2 quarters · filed 2020-12-31 | $0.00 10-Q/A · filed 2020-12-31 | $4.70M derived: sum of 4 quarters · filed 2020-12-31 | ||||||
| 2019-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | $0.00 10-Q/A · filed 2020-12-30 | $4.70M derived: sum of 3 quarters · filed 2020-12-30 | $4.67M derived: sum of 4 quarters · filed 2020-12-30 | ||||||
| 2018-12-31 | $0.00 10-Q/A · filed 2020-12-30 | $4.70M derived: sum of 2 quarters · filed 2020-12-30 | $4.67M derived: sum of 3 quarters · filed 2020-12-30 | $9.37M derived: sum of 4 quarters · filed 2020-12-30 | ||||||
| 2018-09-30 | $4.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $4.67M derived: sum of 2 quarters · filed 2019-12-23 | $9.37M derived: sum of 3 quarters · filed 2019-12-23 | $11.79M 10-K/A · filed 2019-12-23 | $11.60M 10-K · filed 2018-12-19 | |||||
| 2018-06-30 | -$35.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $4.67M derived: sum of 2 quarters · filed 2019-08-14 | $7.09M 10-Q · filed 2019-08-14 | $7.00M 10-Q · filed 2018-08-14 | $10.44M derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $7.13M 10-Q · filed 2019-05-14 | $7.07M 10-Q · filed 2018-05-15 | $10.48M derived: sum of 3 quarters · filed 2019-05-14 | $11.80M derived: sum of 4 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $2.42M 10-Q · filed 2019-02-14 | $2.39M 10-Q · filed 2018-02-12 | $5.78M derived: sum of 2 quarters · filed 2019-02-14 | $7.09M derived: sum of 3 quarters · filed 2019-02-14 | $9.23M derived: sum of 4 quarters · filed 2019-02-14 | |||||
| 2017-09-30 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $4.67M derived: sum of 2 quarters · filed 2018-12-19 | $6.81M derived: sum of 3 quarters · filed 2018-12-19 | $10.52M 10-K · filed 2018-12-19 | ||||||
| 2017-06-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $3.46M derived: sum of 2 quarters · filed 2018-08-14 | $7.17M 10-Q · filed 2018-08-14 | $11.73M derived: sum of 4 quarters · filed 2018-08-14 | ||||||
| 2017-03-31 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $5.85M 10-Q · filed 2018-05-15 | $10.41M derived: sum of 3 quarters · filed 2018-05-15 | $15.01M derived: sum of 4 quarters · filed 2018-05-15 | ||||||
| 2016-12-31 | $3.71M 10-Q · filed 2018-02-12 | $8.27M derived: sum of 2 quarters · filed 2018-02-12 | $12.87M derived: sum of 3 quarters · filed 2018-02-12 | $14.58M derived: sum of 4 quarters · filed 2018-02-12 | ||||||
| 2016-09-30 | $4.56M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | $9.16M derived: sum of 2 quarters · filed 2017-12-29 | $10.87M derived: sum of 3 quarters · filed 2017-12-29 | $21.42M 10-K · filed 2017-12-29 | ||||||
| 2016-06-30 | $4.60M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $6.31M derived: sum of 2 quarters · filed 2017-12-11 | $16.86M 10-Q/A · filed 2017-12-11 | $16.73M derived: sum of 4 quarters · filed 2017-12-11 | ||||||
| 2016-03-31 | $1.71M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | $12.26M 10-Q/A · filed 2017-12-11 | $12.13M derived: sum of 3 quarters · filed 2017-12-11 | $27.00M derived: sum of 4 quarters · filed 2017-12-11 | ||||||
| 2015-12-31 | $10.55M 10-Q/A · filed 2017-12-11 | $10.42M derived: sum of 2 quarters · filed 2017-12-11 | $25.29M derived: sum of 3 quarters · filed 2017-12-11 | $25.29M derived: sum of 4 quarters · filed 2017-12-11 | ||||||
| 2015-09-30 | -$130.53K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $14.74M derived: sum of 2 quarters · filed 2017-12-11 | $14.74M derived: sum of 3 quarters · filed 2017-12-11 | $21.15M 10-K/A · filed 2017-12-11 | ||||||
| 2015-06-30 | $14.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $14.87M derived: sum of 2 quarters · filed 2016-08-09 | $21.28M 10-Q · filed 2016-08-09 | $21.28M derived: sum of 4 quarters · filed 2017-12-11 | ||||||
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $6.41M 10-Q · filed 2016-05-10 | $6.41M derived: sum of 3 quarters · filed 2017-12-11 | $15.55M derived: sum of 4 quarters · filed 2017-12-11 | ||||||
| 2014-12-31 | $6.41M 10-Q · filed 2016-02-09 | $6.41M derived: sum of 2 quarters · filed 2017-12-11 | $15.55M derived: sum of 3 quarters · filed 2017-12-11 | $15.45M derived: sum of 4 quarters · filed 2017-12-11 | ||||||
| 2014-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $9.14M derived: sum of 2 quarters · filed 2017-12-11 | $9.05M derived: sum of 3 quarters · filed 2017-12-11 | $28.43M 10-K/A · filed 2017-12-11 | ||||||
| 2014-06-30 | $9.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $9.05M derived: sum of 2 quarters · filed 2015-08-07 | $28.43M 10-Q · filed 2015-08-07 | $28.41M derived: sum of 4 quarters · filed 2015-12-11 | ||||||
| 2014-03-31 | -$94.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $19.29M 10-Q · filed 2015-05-08 | $19.27M derived: sum of 3 quarters · filed 2015-12-11 | $19.27M derived: sum of 4 quarters · filed 2015-12-11 | ||||||
| 2013-12-31 | $19.38M 10-Q · filed 2015-02-06 | $19.36M derived: sum of 2 quarters · filed 2015-12-11 | $19.36M derived: sum of 3 quarters · filed 2015-12-11 | $19.36M derived: sum of 4 quarters · filed 2015-12-11 | ||||||
| 2013-09-30 | -$18.61K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$18.61K derived: sum of 2 quarters · filed 2015-12-11 | -$18.61K derived: sum of 3 quarters · filed 2015-12-11 | $9.79M 10-K · filed 2015-12-11 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | $0.00 derived: sum of 2 quarters · filed 2014-08-08 | $9.81M 10-Q · filed 2014-08-08 | $9.81M derived: sum of 4 quarters · filed 2014-12-23 | ||||||
| 2013-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $9.81M 10-Q · filed 2014-05-12 | $9.81M derived: sum of 3 quarters · filed 2014-12-23 | $14.93M derived: sum of 4 quarters · filed 2014-12-23 | ||||||
| 2012-12-31 | $9.81M 10-Q · filed 2014-02-10 | $9.81M derived: sum of 2 quarters · filed 2014-12-23 | $14.93M derived: sum of 3 quarters · filed 2014-12-23 | $20.29M derived: sum of 4 quarters · filed 2014-12-23 | ||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $5.12M derived: sum of 2 quarters · filed 2014-12-23 | $10.48M derived: sum of 3 quarters · filed 2014-12-23 | $14.29M 10-K · filed 2014-12-23 | ||||||
| 2012-06-30 | $5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | $10.48M derived: sum of 2 quarters · filed 2013-08-09 | $14.29M 10-Q · filed 2013-08-09 | $18.23M derived: sum of 4 quarters · filed 2013-12-27 | ||||||
| 2012-03-31 | $5.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-10 | $9.17M 10-Q · filed 2013-05-10 | $13.10M derived: sum of 3 quarters · filed 2013-12-27 | $11.70M derived: sum of 4 quarters · filed 2013-12-27 | ||||||
| 2011-12-31 | $3.81M 10-Q · filed 2013-02-08 | $7.75M derived: sum of 2 quarters · filed 2013-12-27 | $6.34M derived: sum of 3 quarters · filed 2013-12-27 | $7.75M derived: sum of 4 quarters · filed 2013-12-27 | ||||||
| 2011-09-30 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $2.53M derived: sum of 2 quarters · filed 2013-12-27 | $3.94M derived: sum of 3 quarters · filed 2013-12-27 | $3.94M 10-K · filed 2013-12-27 | ||||||
| 2011-06-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | $0.00 derived: sum of 2 quarters · filed 2012-08-09 | $0.00 10-Q · filed 2012-08-09 | |||||||
| 2011-03-31 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-10 | $1.41M 10-Q · filed 2012-05-10 | ||||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-09 | |||||||||
| 2009-09-30 | $32.24M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |